Cargando…
Percutaneous ablation of pancreatic cancer
Pancreatic ductal adenocarcinoma is a highly aggressive tumor with an overall 5-year survival rate of less than 5%. Prognosis and treatment depend on whether the tumor is resectable or not, which mostly depends on how quickly the diagnosis is made. Chemotherapy and radiotherapy can be both used in c...
Autores principales: | D’Onofrio, Mirko, Ciaravino, Valentina, De Robertis, Riccardo, Barbi, Emilio, Salvia, Roberto, Girelli, Roberto, Paiella, Salvatore, Gasparini, Camilla, Cardobi, Nicolò, Bassi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124972/ https://www.ncbi.nlm.nih.gov/pubmed/27956791 http://dx.doi.org/10.3748/wjg.v22.i44.9661 |
Ejemplares similares
-
The borderline resectable/locally advanced pancreatic ductal adenocarcinoma staging with computed tomography/magnetic resonance imaging
por: D’Onofrio, Mirko, et al.
Publicado: (2017) -
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms
por: D’Onofrio, Mirko, et al.
Publicado: (2019) -
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review
por: Paiella, Salvatore, et al.
Publicado: (2016) -
Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018) -
An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging
por: Cardobi, Nicolò, et al.
Publicado: (2021)